In a dramatic confrontation, a member of the Federal Reserve Board of Governors disputes President Trump’s authority to fire her. Drugmaker Eli Lilly claims a GLP-1 is on track for FDA approval after a successful trial. And while Indiana Republicans consider a new congressional map, a judge tells Utah to examine their current one.

See Full Page